Agreed, hopefully it will all be worth it in the end.
I personally see the SP sitting around the current price until the end of July when the retail SPP shares hit the market.
The big unknown for me is where funds are coming from to run the phase 2/3 trial? Current CR for preparation, but the source of funds for the actual trial weren’t addressed?
I think a second CR on the horizon would also be weighing on the SP.
Looking forward to the presentations next week to get a better idea
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-765
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.5¢ | $177.2K | 929.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 499621 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |